SlideShare a Scribd company logo
Speaker: Dr.PARMINDER SINGH
Chairperson: Dr.B.L.BHARDWAJ
APPROACH TO A PATIENT WITH HEADACHE
1
 To learn about the major types of
headaches
 To understand the difference between
primary and secondary headaches
 Be familiar with the ‘RED FLAGS’
 To understand when and how to
investigate headache
2
 Extra-cranial pain
sensitive structures:
◦ Sinuses
◦ Eyes/orbits
◦ Ears
◦ Teeth
◦ TMJ
◦ Blood vessels
 Intra-cranial pain
sensitive structures:
◦ Arteries
◦ Veins
◦ Meninges
◦ Dura
3
 Sensory stimuli from head are conveyed to
CNS via-
 Trigeminal nerves- for structures above the
tentorium in the anterior and middle fossae
of the skull
 C1, C2, C3 – for structures in the posterior
fossa and inferior surface of tentorium
4
 Broadly headaches are divided primarily into
2 main types by Headache classification
committee of International Headache Society:
 PRIMARY HEADACHES - Those in which
headache and its associated features are
disease in themselves
 SECONDARY HEADACHES – Those that are
caused exogenously
5
 The Primary Headaches
 1. Migraine
 2. Tension-type headache
 3. Cluster headache and other trigeminal
autonomic cephalgias
 4.Other primary headaches:-
 a. Primary stabbing headache
 b. Primary cough headache
 c. Primary exertional headache
6
 d. Primary headache associated with
sexual activity – Pre orgasmic
 - Orgasmic
 e.Hypnic headache
 f. Primary thunderclap headache
 g. Hemicrania continua
 h. New daily persistant headache
7
8
 The Secondary Headaches
 Headache attributed to –
 1. Head and/or neck trauma
 2. Cranial or cervical vascular disorder
 3. Non-vascular intracranial disorder
 4. Substance or its withdrawal
 5. Infection
 6. Disorder of homeostasis

9
 7. Disorder of cranium, neck, eyes, ears,
nose, sinuses, teeth, mouth, or other facial or
cranial structures.
 8. Psychiatric disorders
 Cranial neuralgias, central and primary
facial pain and other headaches

10
11
12
 RED FLAGS
 1. Head or neck injury
 2. New onset or new type or worsening
pattern of existing headache
 3. New level of pain(e.g. worst ever)
 4. Abrupt or split-second onset
 5. Triggered by valsalva manouvre/cough
 6. Triggered by exertion
 7. Triggered by sexual activity
 8. Headache during pregnancy/peurperium
13
 9. Age>50 yrs
 10. Neurological signs/symptoms
 11. Systemic illness
 a. Fever
 b. Nuchal rigidity
 c. Weight loss
 d. Scalp artery tenderness
 12. Secondary risk factors
 a. Cancer
 b. Immunocompromised host
 c. Recent travel
14
 YELLOW FLAGS
 1. Wakes patient from sleep at night
 2. New onset side – locked headache
 3. Postural headaches
15
 RED FLAGS
 Head or neck
injury
 CONSIDERATIONS
 Hemorrhage
 Epidural
 Subdural
 Subarachnoid
 Intraparenchymal
 Dissection
 Carotid arteries
 Vertebral arteries
16
 New onset or new
type or worsening
pattern of existing
headache
 New level of pain
(e.g. “worst ever”)
 Mass lesion
 Subdural hematoma
 Medication overuse
 Meningoencephaliti
s
 Subarachnoid
hemorrhage
17
 Abrupt or split-second
onset
 Intraparenchymal
hemorrhage
 Bleed into a mass or AVM
 Dissection
 Cerebral venous thrombosis
 Pituitary apoplexy
 Spontaneous intracranial
hypotension
 Reversible cerebral
vasoconstriction syndrome
 Acute hypertensive crisis
 Mass lesion esp.post fossa
 Primary thunderclap
headache
18
 Triggered by
Valsalva manouver
or cough
 Triggered by
exertion
 Chiari malformation
 Mass lesion
 Subarachnoid
hemorrhage
 Dissection
 Angina equivalent
 Pheochromocytoma
19
 Triggered by sexual
activity( Pre-
orgasmic,orgasmic)
 Headache during
pregnancy or
puerperium
 Subarachnoid
hemorrhage
 Dissection
 Cortical
venous/cranial
sinus thrombosis
 Pituitary apoplexy
20
 Age > 50 yrs
 Neurologicalsigns or
symptoms(seizures,con
fusion,impaired
alertness,weakness,
papilloedema etc.)
 Brain tumour(primary,
metastatic)
 Cerebrovascular
diseases
 Giant cell arteritis
 Mass lesion
 AVM
 CTD
 Benign intracranial
hypertension
 Meningoencephalitis
21
 Systemic illness
 Fever
 Nuchal rigidity
 Weight loss
 Scalp artery
tenderness
 Meningoencephalitis
 Meningeal
carcinomatosis
 Lyme disease
 Collagen vascular
diseases
 Malignancy
 Giant cell arteritis
22
 Secondary risk
factors
 Cancer

Immunocompromis
ed host
 Recent travel
 Metastatic disease
 Opportunistic
infection
 Meningoencephaliti
s
23
 YELLOW FLAGS
 Wakes patient from
sleep at night
 Sleep related
disorders(e.g.
Obstructive sleep
apnea)
 Rebound
withdrawal
headaches
 Poorly controlled
hypertension
24
 New onset side-
locked headaches
 Postural headaches
 Head trauma
 Dissection
 Intracranial aneurysm
 Lung carcinoma
 Spontaneous
intracranial
hypotension
 Post lumbar puncture
headache
25
 Affects 15% of the general population
 Female > Males
 Family History present in 70%
 Pathophysiology: vascular vs neurologic
 Precipitants: caffeine, chocolate, alcohol,
cheese, BCP/HRT, menses, stress
26
 Diagnostic criteria:
1. 5 attacks in 6 months
2. Headaches lasting 4-72 h with >/= 2:
- unilateral
- pulsatile
- moderate to severe in intensity
- aggravated by activity
3. Associated with >/= 1:
- nausea/vomiting
- photophobia/phonophobia
27
 Subtypes:
◦ Auras – visual or sensory
◦ Scintillating scotoma
◦ Fortification spectra
◦ Ophthalmoplegic
◦ CN III palsy
◦ Vertbrobasilar
◦ hemiplegic
28
Scintillating Scotomas
Progression of a typical aura
over 30 minutes
BMJ 2002; 325:881-6 29
 Mild attacks: NSAIDS +/- dopamine
antagonists
◦ eg. ASA 650-1300 mg q4h + metoclopromide 10
mg PO/IV
 Moderate attacks:
◦ NSAIDS (ibuprofen 400-800 mg PO q2-6h)
◦ 5-HT1 receptor agonists
 Selective – sumatriptan 50-100 mg PO
 Nonselective – ergot 1-2 mg PO q1h x 3
CMAJ 1997; 156: 1273-87 30
 Severe & Ultra-severe attacks:
◦ First line:
 DHE 0.5-1 mg q1h IM/SC/IV
 sumatriptan 50-100 mg PO or 6 mg SC
◦ Second line:
 chlorpromazine 50 mg IM
 Prochlorperazine 5-10 mg IV/IM
 dexamethasone 12-20 mg IV
CMAJ 1997; 156: 1273-87 31
 Consider if >/3 attacks/month, impaired
quality of life:
◦ B-blockers
◦ Calcium channel blockers
◦ TCA (amitriptyline)
◦ NSAIDS
◦ Valproic acid
◦ 5HT2 Antagonists (methysergide, pizotyline)
CMAJ 1997; 156: 1273-87
32
 Most common type, typically brought on by
stress, lasting 30 min to 7 d
 Diagnostic Criteria >/= 2:
◦ Pressing/tightening, non-pulsating
◦ Mild-moderate
◦ Bilateral
◦ Not worsened by ADLs
◦ Photo or phonophobia (not coincident)
◦ Not associated with N/V
 Treatment: reassurance, NSAIDS
33
 Diagnostic criteria:-
 A. At least 5 attacks fulfilling B-D;
 B. Severe or very severe unilateral orbital, supraorbital,
and/or temporal pain lasting 15-180 min if untreated;
 C. Headache is accompanied by at least 1 of the following:
 1. I/L conj. Injection/lacrimation
 2. I/L nasal congestion/rhinorrhoea
 3. I/L forehaed and facial swelling
 4. I/L eyelid edema
 5. I/L miosis and/or ptosis
 6. A sense of restlessness/agitation
 D. Attacks have frequency from 1 every other day to 8/day
34
35
36
37
PRIMARY STABBING HEADACHE
 Pain confined to head, rarely facial.
 Stabbing pain lasting 1 to many sec and occuring as a single stab
or series of stabs
 Recurring at intervals of hours to days
 PRIMARY COUGH HEADACHE
 B/L headache of sudden onset, lasting minutes, precipitated by
coughing
 Prevented by avoiding coughing
 Diagnosed only after structural lesions, such as posterior fossa
tumour, have been excluded by neuroimaging
38
 HYPNIC HEADACHE
 Headache of moderate to severe nature that
typically occur few hrs after going to sleep
 Last from 15–30 mins
 Typically generalised although may be
unilateral and can be throbbing
 Falling back to sleep only to be awoken by
further attack few hrs later with upto 3
repetitions of this pattern over night
39
THUNDERCLAP HEADACHES
40
 PRIMARY THUNDERCLAP
HEADACHE(TCH)
 Defined as severe headache reaching maximal
intensity within seconds to a minute
 Thunderclap headache is a NEUROLOGICAL
EMERGENCY
 Numerous etiologies ranging from benign to
life-threatening have been reported most
notable being aneurysmal subarachnoid
hemorrhage
41
 DISORDERS A/W TCH:-
 1. Subarachnoid hemorrhage
 2. Unruptured intracranial aneurysm(“Sentinal
Headache”)
 3. Cervical artery dissection
 4. Stroke( H’ragic>Ischemic)
 5. Cerebral venous sinus thrombosis
42
 6. Intraparenchymal hemorrhage
 7. Spontaneous intracranial hypotension
 8. Reversible cerebral vasoconstrictn synd.
 9. Reversible post. Leukoencephalopathy
 10. Infections- intracranial,sinusitis
 11. Primary TCH
43
 REVERSIBLE CEREBRAL VASOCONSTRICTION
SYNDROME:-
 Diagnostic criteria-
 1. TCH with/without other neurological signs/symptoms
 2. No evidence for aneurysmal SAH
 3. Normal/near normal CSF
 4. Angiographic documentation of multifocal segmental
cerebral artery vasoconstriction
 5. Reversal of vasoconstriction within 12 wks of onset
44
 RCVS includes-
 1. Call-Fleming syndrome
 2. Benign angiopathy of CNS
 3. CNS pseudovasculitis
 4. Isolated benign cerebral vasculitis
 5. Benign acute cerebral vasculopathy
45
 6. Drug induced cerebral
vasculopathy(cannabis,sympathomimetic,serotonergi
c agents)
 7. Postpartum angiopathy
 8.Acute hypertension(Pheochromocytoma)
 9.Reversible Posterior Leukoencephalopathy
 10. Bath headache
 11. Orgasmic headache
46
 CVS- CCBs
 Antiarrhythmics
 α1 adrenergic antagonists
 α2 adrenergic agonists
 β adrenergic antagonists
 ACE inhibitors
 Angiotensin II inhibitors
 Nitrates
 Diuretics
 Phosphodiesterase inhibitors
 Antimicrobials
 Immunologic/antiinflammatory
47
 Gastrointestinal- H2 blockers/ PPIs
 5HT3 antagonists
 Endocrinological- Gonadotropin inhibitors
 Dopamine receptor agonists
 Psychiatric- Antidepressants/antipsychotics
 Sedative/hypnotics
 Misc- Antiobesity
 Statins
 Retinoids
 Prostaglandins
 Agents for erectile dysfunction
48
 Primary
 >4hrs daily-
 1. Chr. Migraine
 2. Chr. Tension
headache
 3. Hemicrania continua
 4. New daily persistant
headache
 Secondary
 1. Post traumatic
 2. Inflammatory
 3. Chr CNS infection
 4. Substance abuse
headache
49
 <4 hrs
 1. Chr. Cluster
headacahe
 2. Chr. paroxysmal
hemicrania
 3. SUNCT
 4. Hypnic headaache
50
 Primary
 1.Migranious type
 2.Featureless(tension-
type)
 Secondary
 1. SAH
 2. Low CSF volume
headache
 3. Raised CSF volume
headache
 4. Post traumatic
 5. Chr. Meningitis
51
 1. Imaging studies:
 CT and MRI
 Plain X-ray films
 Cerebral angiography- MRA and CTA
 Myelography and radioisotope cisternography
 2. CSF examination
 3. Electrophysiological testing
 4. General medical tests
52
 MRI preferred:-
 1. Vascular disease- Cerebral/venous
infarction
 2. Neoplastic disease
 a. Brain tumors esp. in POST. FOSSA
 b. Skull base tumors
 c. Meningeal carcinomatosis
 d. Pituitary tumors
53
 3. Infections- Cerebritis/abscess/meningitis
/encephalitis
 4. Others- Chiari malformation
 CSF hypotension
 Foramen magnum/upper Cx
spine lesions
 Pituitary apoplexy
 CADASIL,MELAS,SMART
54
 CT preferred:-
 1. Fractures (calvarium)
 2. Acute hemorrhage (SAH,intracerebral)
 3. Paranasal sinus and mastoid air cells Diseases
 Draw b/w MRI/CT:-
 MR/CT angiography- Vasculitis
 Intracranial aneurysm
 Dissections
 MR/CT venography- Cerebral venous thrombosis
55
 CT
 - Increased lifetime risk of cancer
 - Anaphylaxis and renal insufficiency
 MRI
 - Increased detection of incidental
findings
 - Nephrogenic systemic fibrosis
56
 Cerebral angiography
 - Access site hematoma (4.2%)
 - Strokes(0.14%)
 - Deaths(0.06%)
 LP
 - Post-LP headaches
 - Persistent CSF leaks
 - Bleeding
 - Low back pain
 - Infection

57
 It is important to differentiate between Primary
and Secondary Headaches
 “HISTORY” is the most important diagnostic tool
in evaluation of headache
 Early recognition of RED FLAGS in a case of
headache is invaluable
 Not all cases of headache require neuroimaging,
judicious use of investigations must be done
weighing their benefits and harms…
58
59

More Related Content

What's hot (20)

Headache
HeadacheHeadache
Headache
 
Approach to headache
Approach to headacheApproach to headache
Approach to headache
 
Headache
HeadacheHeadache
Headache
 
Headache
Headache  Headache
Headache
 
Headache
HeadacheHeadache
Headache
 
Headache
HeadacheHeadache
Headache
 
Headache ppt
Headache pptHeadache ppt
Headache ppt
 
Primary headache
Primary headachePrimary headache
Primary headache
 
Headache (tension type headache, migraine)
Headache (tension type headache, migraine)Headache (tension type headache, migraine)
Headache (tension type headache, migraine)
 
Headache : Causes and management
Headache : Causes and managementHeadache : Causes and management
Headache : Causes and management
 
Headache
HeadacheHeadache
Headache
 
Headache
Headache Headache
Headache
 
Approach to headaches
Approach to headachesApproach to headaches
Approach to headaches
 
Vertigo
VertigoVertigo
Vertigo
 
Tension Type Headache (TTH)
Tension Type Headache (TTH)Tension Type Headache (TTH)
Tension Type Headache (TTH)
 
MIGRAINE
MIGRAINEMIGRAINE
MIGRAINE
 
Acute Headache Mw
Acute Headache MwAcute Headache Mw
Acute Headache Mw
 
Vertigo
VertigoVertigo
Vertigo
 
Headache management
Headache management Headache management
Headache management
 
Headache
HeadacheHeadache
Headache
 

Viewers also liked

Viewers also liked (11)

How to write a neuroimaging paper
How to write a neuroimaging paperHow to write a neuroimaging paper
How to write a neuroimaging paper
 
Migraine and medication overused
Migraine and medication overusedMigraine and medication overused
Migraine and medication overused
 
Headache
HeadacheHeadache
Headache
 
Headache
HeadacheHeadache
Headache
 
Approach to headache
Approach to headacheApproach to headache
Approach to headache
 
Primary headache
Primary headachePrimary headache
Primary headache
 
Migraine
MigraineMigraine
Migraine
 
HEADACHE - CLASSIFICATION
HEADACHE - CLASSIFICATIONHEADACHE - CLASSIFICATION
HEADACHE - CLASSIFICATION
 
Migraine and tension headache
Migraine and tension headacheMigraine and tension headache
Migraine and tension headache
 
Migraine
MigraineMigraine
Migraine
 
Migraine
MigraineMigraine
Migraine
 

Similar to Approach to a_case_of_headache

Diagnosing Secondary
Diagnosing SecondaryDiagnosing Secondary
Diagnosing SecondaryMohamadAlhes
 
HEADACHE NEUROIMAGING FINAL.pptx by sms medical college
HEADACHE NEUROIMAGING FINAL.pptx by sms medical collegeHEADACHE NEUROIMAGING FINAL.pptx by sms medical college
HEADACHE NEUROIMAGING FINAL.pptx by sms medical collegedineshdandia
 
Headache & Facial pain
Headache & Facial painHeadache & Facial pain
Headache & Facial painyuyuricci
 
Headache with Special Reference to Migraine
Headache with Special Reference to MigraineHeadache with Special Reference to Migraine
Headache with Special Reference to MigraineAbinayaa Arasu
 
neurobiology of neuroglia Applied dr ameer abbas final .pptx
neurobiology of neuroglia Applied dr ameer abbas final .pptxneurobiology of neuroglia Applied dr ameer abbas final .pptx
neurobiology of neuroglia Applied dr ameer abbas final .pptxameerabdullah29
 
Rare headache syndromes
Rare headache syndromesRare headache syndromes
Rare headache syndromesSucharita Ray
 
Hemorrhagic stroke final final
Hemorrhagic stroke   final finalHemorrhagic stroke   final final
Hemorrhagic stroke final finalR C
 
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptx
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptxayu w - PROBLEM 7 EMERGENCY MEDICINE.pptx
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptxAyuWindyaningrum
 
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptx
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptxTRAUMATIC BRAIN INJURY NEurosugery presentation.pptx
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptxRUTAYISIRE François Xavier
 
Headache Lecture For Student
Headache Lecture For StudentHeadache Lecture For Student
Headache Lecture For Studentmed
 
Headache lecture for student2
Headache lecture for student2Headache lecture for student2
Headache lecture for student2udom
 
Seminar rare headache syndromes
Seminar rare headache syndromesSeminar rare headache syndromes
Seminar rare headache syndromesSucharita Ray
 
iNTRODUCTION TO HEADACHE
iNTRODUCTION TO HEADACHEiNTRODUCTION TO HEADACHE
iNTRODUCTION TO HEADACHEDR.UMAR MUSHIR
 

Similar to Approach to a_case_of_headache (20)

Aprroach to Headache.pptx
Aprroach  to Headache.pptxAprroach  to Headache.pptx
Aprroach to Headache.pptx
 
Diagnosing Secondary
Diagnosing SecondaryDiagnosing Secondary
Diagnosing Secondary
 
HEADACHE NEUROIMAGING FINAL.pptx by sms medical college
HEADACHE NEUROIMAGING FINAL.pptx by sms medical collegeHEADACHE NEUROIMAGING FINAL.pptx by sms medical college
HEADACHE NEUROIMAGING FINAL.pptx by sms medical college
 
headaches.pptx
headaches.pptxheadaches.pptx
headaches.pptx
 
Headache & Facial pain
Headache & Facial painHeadache & Facial pain
Headache & Facial pain
 
Headache with Special Reference to Migraine
Headache with Special Reference to MigraineHeadache with Special Reference to Migraine
Headache with Special Reference to Migraine
 
neurobiology of neuroglia Applied dr ameer abbas final .pptx
neurobiology of neuroglia Applied dr ameer abbas final .pptxneurobiology of neuroglia Applied dr ameer abbas final .pptx
neurobiology of neuroglia Applied dr ameer abbas final .pptx
 
Rare headache syndromes
Rare headache syndromesRare headache syndromes
Rare headache syndromes
 
HEADACHE.pptx
HEADACHE.pptxHEADACHE.pptx
HEADACHE.pptx
 
Hemorrhagic stroke final final
Hemorrhagic stroke   final finalHemorrhagic stroke   final final
Hemorrhagic stroke final final
 
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptx
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptxayu w - PROBLEM 7 EMERGENCY MEDICINE.pptx
ayu w - PROBLEM 7 EMERGENCY MEDICINE.pptx
 
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptx
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptxTRAUMATIC BRAIN INJURY NEurosugery presentation.pptx
TRAUMATIC BRAIN INJURY NEurosugery presentation.pptx
 
Headache Lecture For Student
Headache Lecture For StudentHeadache Lecture For Student
Headache Lecture For Student
 
Headache lecture for student2
Headache lecture for student2Headache lecture for student2
Headache lecture for student2
 
Headache,ppt
Headache,ppt Headache,ppt
Headache,ppt
 
Headache
HeadacheHeadache
Headache
 
Seminar rare headache syndromes
Seminar rare headache syndromesSeminar rare headache syndromes
Seminar rare headache syndromes
 
iNTRODUCTION TO HEADACHE
iNTRODUCTION TO HEADACHEiNTRODUCTION TO HEADACHE
iNTRODUCTION TO HEADACHE
 
Head injuries
Head injuriesHead injuries
Head injuries
 
Migrine :pain management.
Migrine :pain management.Migrine :pain management.
Migrine :pain management.
 

More from Mohit Aggarwal

Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Mohit Aggarwal
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajeshMohit Aggarwal
 
Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Mohit Aggarwal
 
Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Mohit Aggarwal
 
Approach to the_patient_with_myopathy
Approach to the_patient_with_myopathyApproach to the_patient_with_myopathy
Approach to the_patient_with_myopathyMohit Aggarwal
 
Approach to pituitary_tumours
Approach to pituitary_tumoursApproach to pituitary_tumours
Approach to pituitary_tumoursMohit Aggarwal
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsMohit Aggarwal
 
Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Mohit Aggarwal
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Mohit Aggarwal
 
Approach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepApproach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepMohit Aggarwal
 
Antithrombotic in difficul clinical condition umesh
Antithrombotic in difficul clinical condition  umeshAntithrombotic in difficul clinical condition  umesh
Antithrombotic in difficul clinical condition umeshMohit Aggarwal
 
Antibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalAntibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalMohit Aggarwal
 
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Mohit Aggarwal
 

More from Mohit Aggarwal (20)

Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajesh
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
 
Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)
 
Ards
ArdsArds
Ards
 
Approachto cp
Approachto cpApproachto cp
Approachto cp
 
Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)
 
Approach to the_patient_with_myopathy
Approach to the_patient_with_myopathyApproach to the_patient_with_myopathy
Approach to the_patient_with_myopathy
 
Approach to pituitary_tumours
Approach to pituitary_tumoursApproach to pituitary_tumours
Approach to pituitary_tumours
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)
 
Approach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepApproach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeep
 
Aphasia nikhil
Aphasia nikhilAphasia nikhil
Aphasia nikhil
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Antithrombotic in difficul clinical condition umesh
Antithrombotic in difficul clinical condition  umeshAntithrombotic in difficul clinical condition  umesh
Antithrombotic in difficul clinical condition umesh
 
Antibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalAntibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 final
 
Andropause
AndropauseAndropause
Andropause
 
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
 
Ai hepatitis dr rintu
Ai hepatitis dr rintuAi hepatitis dr rintu
Ai hepatitis dr rintu
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaasiemaillard
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resourcesdimpy50
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online PresentationGDSCYCCE
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXMIRIAMSALINAS13
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345beazzy04
 
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...Denish Jangid
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesRased Khan
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chipsGeoBlogs
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfVivekanand Anglo Vedic Academy
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleCeline George
 
NLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptxNLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptxssuserbdd3e8
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportAvinash Rai
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...Sayali Powar
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxJenilouCasareno
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfjoachimlavalley1
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptSourabh Kumar
 
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdfINU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdfbu07226
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxShibin Azad
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxakshayaramakrishnan21
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matrices
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
NLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptxNLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptx
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdfINU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptx
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptx
 

Approach to a_case_of_headache

  • 1. Speaker: Dr.PARMINDER SINGH Chairperson: Dr.B.L.BHARDWAJ APPROACH TO A PATIENT WITH HEADACHE 1
  • 2.  To learn about the major types of headaches  To understand the difference between primary and secondary headaches  Be familiar with the ‘RED FLAGS’  To understand when and how to investigate headache 2
  • 3.  Extra-cranial pain sensitive structures: ◦ Sinuses ◦ Eyes/orbits ◦ Ears ◦ Teeth ◦ TMJ ◦ Blood vessels  Intra-cranial pain sensitive structures: ◦ Arteries ◦ Veins ◦ Meninges ◦ Dura 3
  • 4.  Sensory stimuli from head are conveyed to CNS via-  Trigeminal nerves- for structures above the tentorium in the anterior and middle fossae of the skull  C1, C2, C3 – for structures in the posterior fossa and inferior surface of tentorium 4
  • 5.  Broadly headaches are divided primarily into 2 main types by Headache classification committee of International Headache Society:  PRIMARY HEADACHES - Those in which headache and its associated features are disease in themselves  SECONDARY HEADACHES – Those that are caused exogenously 5
  • 6.  The Primary Headaches  1. Migraine  2. Tension-type headache  3. Cluster headache and other trigeminal autonomic cephalgias  4.Other primary headaches:-  a. Primary stabbing headache  b. Primary cough headache  c. Primary exertional headache 6
  • 7.  d. Primary headache associated with sexual activity – Pre orgasmic  - Orgasmic  e.Hypnic headache  f. Primary thunderclap headache  g. Hemicrania continua  h. New daily persistant headache 7
  • 8. 8
  • 9.  The Secondary Headaches  Headache attributed to –  1. Head and/or neck trauma  2. Cranial or cervical vascular disorder  3. Non-vascular intracranial disorder  4. Substance or its withdrawal  5. Infection  6. Disorder of homeostasis  9
  • 10.  7. Disorder of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial or cranial structures.  8. Psychiatric disorders  Cranial neuralgias, central and primary facial pain and other headaches  10
  • 11. 11
  • 12. 12
  • 13.  RED FLAGS  1. Head or neck injury  2. New onset or new type or worsening pattern of existing headache  3. New level of pain(e.g. worst ever)  4. Abrupt or split-second onset  5. Triggered by valsalva manouvre/cough  6. Triggered by exertion  7. Triggered by sexual activity  8. Headache during pregnancy/peurperium 13
  • 14.  9. Age>50 yrs  10. Neurological signs/symptoms  11. Systemic illness  a. Fever  b. Nuchal rigidity  c. Weight loss  d. Scalp artery tenderness  12. Secondary risk factors  a. Cancer  b. Immunocompromised host  c. Recent travel 14
  • 15.  YELLOW FLAGS  1. Wakes patient from sleep at night  2. New onset side – locked headache  3. Postural headaches 15
  • 16.  RED FLAGS  Head or neck injury  CONSIDERATIONS  Hemorrhage  Epidural  Subdural  Subarachnoid  Intraparenchymal  Dissection  Carotid arteries  Vertebral arteries 16
  • 17.  New onset or new type or worsening pattern of existing headache  New level of pain (e.g. “worst ever”)  Mass lesion  Subdural hematoma  Medication overuse  Meningoencephaliti s  Subarachnoid hemorrhage 17
  • 18.  Abrupt or split-second onset  Intraparenchymal hemorrhage  Bleed into a mass or AVM  Dissection  Cerebral venous thrombosis  Pituitary apoplexy  Spontaneous intracranial hypotension  Reversible cerebral vasoconstriction syndrome  Acute hypertensive crisis  Mass lesion esp.post fossa  Primary thunderclap headache 18
  • 19.  Triggered by Valsalva manouver or cough  Triggered by exertion  Chiari malformation  Mass lesion  Subarachnoid hemorrhage  Dissection  Angina equivalent  Pheochromocytoma 19
  • 20.  Triggered by sexual activity( Pre- orgasmic,orgasmic)  Headache during pregnancy or puerperium  Subarachnoid hemorrhage  Dissection  Cortical venous/cranial sinus thrombosis  Pituitary apoplexy 20
  • 21.  Age > 50 yrs  Neurologicalsigns or symptoms(seizures,con fusion,impaired alertness,weakness, papilloedema etc.)  Brain tumour(primary, metastatic)  Cerebrovascular diseases  Giant cell arteritis  Mass lesion  AVM  CTD  Benign intracranial hypertension  Meningoencephalitis 21
  • 22.  Systemic illness  Fever  Nuchal rigidity  Weight loss  Scalp artery tenderness  Meningoencephalitis  Meningeal carcinomatosis  Lyme disease  Collagen vascular diseases  Malignancy  Giant cell arteritis 22
  • 23.  Secondary risk factors  Cancer  Immunocompromis ed host  Recent travel  Metastatic disease  Opportunistic infection  Meningoencephaliti s 23
  • 24.  YELLOW FLAGS  Wakes patient from sleep at night  Sleep related disorders(e.g. Obstructive sleep apnea)  Rebound withdrawal headaches  Poorly controlled hypertension 24
  • 25.  New onset side- locked headaches  Postural headaches  Head trauma  Dissection  Intracranial aneurysm  Lung carcinoma  Spontaneous intracranial hypotension  Post lumbar puncture headache 25
  • 26.  Affects 15% of the general population  Female > Males  Family History present in 70%  Pathophysiology: vascular vs neurologic  Precipitants: caffeine, chocolate, alcohol, cheese, BCP/HRT, menses, stress 26
  • 27.  Diagnostic criteria: 1. 5 attacks in 6 months 2. Headaches lasting 4-72 h with >/= 2: - unilateral - pulsatile - moderate to severe in intensity - aggravated by activity 3. Associated with >/= 1: - nausea/vomiting - photophobia/phonophobia 27
  • 28.  Subtypes: ◦ Auras – visual or sensory ◦ Scintillating scotoma ◦ Fortification spectra ◦ Ophthalmoplegic ◦ CN III palsy ◦ Vertbrobasilar ◦ hemiplegic 28
  • 29. Scintillating Scotomas Progression of a typical aura over 30 minutes BMJ 2002; 325:881-6 29
  • 30.  Mild attacks: NSAIDS +/- dopamine antagonists ◦ eg. ASA 650-1300 mg q4h + metoclopromide 10 mg PO/IV  Moderate attacks: ◦ NSAIDS (ibuprofen 400-800 mg PO q2-6h) ◦ 5-HT1 receptor agonists  Selective – sumatriptan 50-100 mg PO  Nonselective – ergot 1-2 mg PO q1h x 3 CMAJ 1997; 156: 1273-87 30
  • 31.  Severe & Ultra-severe attacks: ◦ First line:  DHE 0.5-1 mg q1h IM/SC/IV  sumatriptan 50-100 mg PO or 6 mg SC ◦ Second line:  chlorpromazine 50 mg IM  Prochlorperazine 5-10 mg IV/IM  dexamethasone 12-20 mg IV CMAJ 1997; 156: 1273-87 31
  • 32.  Consider if >/3 attacks/month, impaired quality of life: ◦ B-blockers ◦ Calcium channel blockers ◦ TCA (amitriptyline) ◦ NSAIDS ◦ Valproic acid ◦ 5HT2 Antagonists (methysergide, pizotyline) CMAJ 1997; 156: 1273-87 32
  • 33.  Most common type, typically brought on by stress, lasting 30 min to 7 d  Diagnostic Criteria >/= 2: ◦ Pressing/tightening, non-pulsating ◦ Mild-moderate ◦ Bilateral ◦ Not worsened by ADLs ◦ Photo or phonophobia (not coincident) ◦ Not associated with N/V  Treatment: reassurance, NSAIDS 33
  • 34.  Diagnostic criteria:-  A. At least 5 attacks fulfilling B-D;  B. Severe or very severe unilateral orbital, supraorbital, and/or temporal pain lasting 15-180 min if untreated;  C. Headache is accompanied by at least 1 of the following:  1. I/L conj. Injection/lacrimation  2. I/L nasal congestion/rhinorrhoea  3. I/L forehaed and facial swelling  4. I/L eyelid edema  5. I/L miosis and/or ptosis  6. A sense of restlessness/agitation  D. Attacks have frequency from 1 every other day to 8/day 34
  • 35. 35
  • 36. 36
  • 37. 37
  • 38. PRIMARY STABBING HEADACHE  Pain confined to head, rarely facial.  Stabbing pain lasting 1 to many sec and occuring as a single stab or series of stabs  Recurring at intervals of hours to days  PRIMARY COUGH HEADACHE  B/L headache of sudden onset, lasting minutes, precipitated by coughing  Prevented by avoiding coughing  Diagnosed only after structural lesions, such as posterior fossa tumour, have been excluded by neuroimaging 38
  • 39.  HYPNIC HEADACHE  Headache of moderate to severe nature that typically occur few hrs after going to sleep  Last from 15–30 mins  Typically generalised although may be unilateral and can be throbbing  Falling back to sleep only to be awoken by further attack few hrs later with upto 3 repetitions of this pattern over night 39
  • 41.  PRIMARY THUNDERCLAP HEADACHE(TCH)  Defined as severe headache reaching maximal intensity within seconds to a minute  Thunderclap headache is a NEUROLOGICAL EMERGENCY  Numerous etiologies ranging from benign to life-threatening have been reported most notable being aneurysmal subarachnoid hemorrhage 41
  • 42.  DISORDERS A/W TCH:-  1. Subarachnoid hemorrhage  2. Unruptured intracranial aneurysm(“Sentinal Headache”)  3. Cervical artery dissection  4. Stroke( H’ragic>Ischemic)  5. Cerebral venous sinus thrombosis 42
  • 43.  6. Intraparenchymal hemorrhage  7. Spontaneous intracranial hypotension  8. Reversible cerebral vasoconstrictn synd.  9. Reversible post. Leukoencephalopathy  10. Infections- intracranial,sinusitis  11. Primary TCH 43
  • 44.  REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME:-  Diagnostic criteria-  1. TCH with/without other neurological signs/symptoms  2. No evidence for aneurysmal SAH  3. Normal/near normal CSF  4. Angiographic documentation of multifocal segmental cerebral artery vasoconstriction  5. Reversal of vasoconstriction within 12 wks of onset 44
  • 45.  RCVS includes-  1. Call-Fleming syndrome  2. Benign angiopathy of CNS  3. CNS pseudovasculitis  4. Isolated benign cerebral vasculitis  5. Benign acute cerebral vasculopathy 45
  • 46.  6. Drug induced cerebral vasculopathy(cannabis,sympathomimetic,serotonergi c agents)  7. Postpartum angiopathy  8.Acute hypertension(Pheochromocytoma)  9.Reversible Posterior Leukoencephalopathy  10. Bath headache  11. Orgasmic headache 46
  • 47.  CVS- CCBs  Antiarrhythmics  α1 adrenergic antagonists  α2 adrenergic agonists  β adrenergic antagonists  ACE inhibitors  Angiotensin II inhibitors  Nitrates  Diuretics  Phosphodiesterase inhibitors  Antimicrobials  Immunologic/antiinflammatory 47
  • 48.  Gastrointestinal- H2 blockers/ PPIs  5HT3 antagonists  Endocrinological- Gonadotropin inhibitors  Dopamine receptor agonists  Psychiatric- Antidepressants/antipsychotics  Sedative/hypnotics  Misc- Antiobesity  Statins  Retinoids  Prostaglandins  Agents for erectile dysfunction 48
  • 49.  Primary  >4hrs daily-  1. Chr. Migraine  2. Chr. Tension headache  3. Hemicrania continua  4. New daily persistant headache  Secondary  1. Post traumatic  2. Inflammatory  3. Chr CNS infection  4. Substance abuse headache 49
  • 50.  <4 hrs  1. Chr. Cluster headacahe  2. Chr. paroxysmal hemicrania  3. SUNCT  4. Hypnic headaache 50
  • 51.  Primary  1.Migranious type  2.Featureless(tension- type)  Secondary  1. SAH  2. Low CSF volume headache  3. Raised CSF volume headache  4. Post traumatic  5. Chr. Meningitis 51
  • 52.  1. Imaging studies:  CT and MRI  Plain X-ray films  Cerebral angiography- MRA and CTA  Myelography and radioisotope cisternography  2. CSF examination  3. Electrophysiological testing  4. General medical tests 52
  • 53.  MRI preferred:-  1. Vascular disease- Cerebral/venous infarction  2. Neoplastic disease  a. Brain tumors esp. in POST. FOSSA  b. Skull base tumors  c. Meningeal carcinomatosis  d. Pituitary tumors 53
  • 54.  3. Infections- Cerebritis/abscess/meningitis /encephalitis  4. Others- Chiari malformation  CSF hypotension  Foramen magnum/upper Cx spine lesions  Pituitary apoplexy  CADASIL,MELAS,SMART 54
  • 55.  CT preferred:-  1. Fractures (calvarium)  2. Acute hemorrhage (SAH,intracerebral)  3. Paranasal sinus and mastoid air cells Diseases  Draw b/w MRI/CT:-  MR/CT angiography- Vasculitis  Intracranial aneurysm  Dissections  MR/CT venography- Cerebral venous thrombosis 55
  • 56.  CT  - Increased lifetime risk of cancer  - Anaphylaxis and renal insufficiency  MRI  - Increased detection of incidental findings  - Nephrogenic systemic fibrosis 56
  • 57.  Cerebral angiography  - Access site hematoma (4.2%)  - Strokes(0.14%)  - Deaths(0.06%)  LP  - Post-LP headaches  - Persistent CSF leaks  - Bleeding  - Low back pain  - Infection  57
  • 58.  It is important to differentiate between Primary and Secondary Headaches  “HISTORY” is the most important diagnostic tool in evaluation of headache  Early recognition of RED FLAGS in a case of headache is invaluable  Not all cases of headache require neuroimaging, judicious use of investigations must be done weighing their benefits and harms… 58
  • 59. 59